Back to results
US 6,274,552 B1Granted
Composition and method for delivery of biologically-active factors
AssigneeCytImmune Sciences, Inc.
InventorsLawrence Tamarkin, Guilio F. Paciotti
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeCytImmune Sciences, Inc.
InventorsLawrence Tamarkin, Guilio F. Paciotti
Estimating the term…
In accordance with the present invention, a composition and method is provided that allows for the administration of a biologically-active factors to a human or animal. The present invention can be used to treat a disease with a biologically-active factor or combination of biologically-active factors, or can be used to safely vaccinate a human or animal against a biologically-active factor. It can also be used as a method for the delivery of biologically-active factors for the treatment of disease. Additionally, the present invention also includes a method of targeted drug delivery for the treatment of disease through the administration of custom complexes containing of one or more biologically active factors bound to a colloidal metal where at least one of the biologically-active factors is capable of binding a high affinity receptor on a cell surface.
A composition capable of targeting a particular tissue comprising a biologically-active factor selected from the group consisting of TNF-α and lymphotoxin and a target molecule admixed with or bound to a colloidal metal.
A method of administering a biologically-active factor to a human or animal comprising:
A method of treating a human or animal with a cancer or immune disease comprising administering to the human or animal with the cancer or immune disease a therapeutically effective amount of a composition capable of targeting a particular tissue comprising a biologically-active factor selected from the group consisting of TNF-α and lymphotoxin and a target molecule admixed with or bound to a colloidal metal.
A method for the delivery of more than one biologically-active factor comprising administering to a human or animal a composition comprising more than one biologically-active factor selected from the group consisting of TNF-α and lymphotoxin and a target molecule admixed with or bound to a colloidal metal.
A method of treating a human or animal with a cancer comprising administering to the human or animal with the cancer a therapeutically effective amount of a composition comprising a biologically-active factor selected from the group consisting of TNF-α and lymphotoxin admixed with or bound to a colloidal metal.
A method of treating a human or animal with a cancer or immune disease comprising administering to the human or animal with the cancer or immune disease a therapeutically effective amount of a composition comprising a biologically-active factor which is tumor necrosis facto (“TNFα”) admixed with or bound to a colloidal metal.
Dependencies are inferred from the claim text.